Genmab A-S Aktie

244,70EUR 1,40EUR 0,58%
Genmab A-S für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 565131 / ISIN: DK0010272202

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
<
Aktion
Portfolio
Watchlist
>

Personal

2021 2022 2023 2024 2025
Personal am Ende des Jahres 1 212 1 660 2 204 2 682 3 029
Umsatz pro Mitarbeiter in Mio. EUR 7,00 8,79 7,47 8,03 8,12

Bilanz (in Mio. DKK) - Aktiva

2021 2022 2023 2024 2025
Summe Umlaufvermögen 22 736 28 377 33 139 27 854 18 347
Summe Anlagevermögen 1 891 1 901 2 150 17 957 63 520
Summe Aktiva 24 627 30 278 35 289 45 811 81 867

Bilanz (in Mio. DKK) - Passiva

2021 2022 2023 2024 2025
Summe Fremdkapital 2 431 2 837 3 679 9 114 44 683
Summe Eigenkapital 22 196 27 441 31 610 36 697 37 185
Summe Passiva 24 627 30 278 35 289 45 811 81 867

Adresse

Carl Jacobsens Vej 30, 2500 Copenhagen
Internet http://www.genmab.com

Management

Anders Gersel Pedersen
Non-Independent Director
Andrew Carlsen
Vice President & Head-Investor Relations
Anthony Pagano
Chief Financial Officer & Executive Vice President
Brad Bailey
Chief Commercial Officer & Executive VP
Christopher Cozic
Chief People Officer & Executive Vice President
Deirdre P. Connelly
Chairman
Elizabeth G. O'Farrell
Independent Director
Gregory David Emil Mueller
Chief Legal Officer, EVP & General Counsel
Jan G. J. van de Winkel
President & Chief Executive Officer
Judith Klimovsky
Chief Development Officer & Executive VP
Marisol Peron
SVP-Global Communications & Corporate Affairs
Martin Schultz
Non-Independent Director
Martine J. van Vugt
Chief Strategy Officer & Executive Vice President
Michael Kavanagh
Director
Mijke Zachariasse
Non-Independent Director
Paolo Augusto Paoletti
Independent Director
Pernille Lyngvold Erenbjerg
Deputy Chairman
Rayne Waller
Chief Technical Operations Officer & Executive VP
Rolf K. Hoffmann
Independent Director
Tahamtan Ahmadi
Chief Medical Officer & Executive Vice President